ＣＥＡ術前血小板凝集能検査の有用性
スポンサーリンク
概要
- 論文の詳細を見る
Although antiplatelet therapy is usually continued throughout the perioperative period of carotid endarterectomy to reduce the risk of recurrent stroke and other cardiovascular events, individualization still has not been standardized. To evaluate the relationship between preoperative antiplatelet agents and platelet aggregability, we analyzed 42 patients who underwent carotid endarterectomy from August 2005 to May 2006 in our institute. Among the 42, 19 were treated with aspirin alone, 5 with ticlopidine alone, 2 with cilostazol alone, 12 with aspirin and ticlopidine, 3 with aspirin and cilostazol and 1 with aspirin, ticlopidine, and cilostazol. Platelet aggregation in response to platelet agonist was measured in platelet-rich plasma obtained from the brachial vein 2 days prior to surgery. 1 μM and 10 μM ADP, or 2 μg/ml and 5 μg/ml collagen were used as agonists. Aggregation in response to appropriate agonist was inhibited in 73% of the aspirin group and 80% of ticlopidine group. None of the cilostazol group showed effects on aggregability. Patients were divided into 2 groups according to their preoperative platelet aggregability: inhibited (n=3) or non-inhibited (n=39). Intraoperative blood loss was 169.0±23.3 g (144-190 g) or 45.5±31.2 g (9-164 g), respectively. Operation time was 221.7±53.5 min (160-255 min) or 147.3±20.6 min (115-205 min), respectively. The main reason for blood loss and prolonged operation time was oozing from connective tissue. Aggregability in older patients who received multiple antiplatelet agents tended to be inhibited excessively. Taken together, preoperative analysis of platelet aggregability could be useful to reduce the risk of perioperative complication.
- 一般社団法人 日本脳卒中の外科学会の論文
一般社団法人 日本脳卒中の外科学会 | 論文
- 頸部内頸動脈のｎｅａｒ ｏｃｃｌｕｓｉｏｎに対するＳＴＡ‐ＭＣＡ吻合術
- 未破裂脳動脈瘤の外科手術の合併症とその対策―慢性硬膜下血腫および後頭蓋窩出血の発生予防―:―慢性硬膜下血腫および後頭蓋窩出血の発生予防―
- 周術期管理指針に基づいたもやもや病に対する血行再建術:―急性期脳血流評価と予防的降圧の効果と限界―
- 未破裂脳動脈瘤クリッピング術の治療成績‐脳動脈瘤手術初心者の経験‐:―脳動脈瘤手術初心者の経験―
- 脳底動脈上小脳動脈分岐部動脈りゅう５８手術例の検討